These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36235978)

  • 1. The Influence of rhBMP-7 Associated with Nanometric Hydroxyapatite Coatings Titanium Implant on the Osseointegration: A Pre-Clinical Study.
    Bonato RS; Fernandes GVO; Calasans-Maia MD; Mello A; Rossi AM; Carreira ACO; Sogayar MC; Granjeiro JM
    Polymers (Basel); 2022 Sep; 14(19):. PubMed ID: 36235978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior maxilla (Type IV bone) in non-human primates.
    Wikesjö UM; Huang YH; Xiropaidis AV; Sorensen RG; Rohrer MD; Prasad HS; Wozney JM; Hall J
    J Clin Periodontol; 2008 Nov; 35(11):992-1000. PubMed ID: 18976396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of combination of recombinant human bone morphogenetic protein-2 and basic fibroblast growth factor or insulin-like growth factor-I on dental implant osseointegration by confocal laser scanning microscopy.
    Lan J; Wang Z; Wang Y; Wang J; Cheng X
    J Periodontol; 2006 Mar; 77(3):357-63. PubMed ID: 16512749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations.
    Wikesjö UM; Qahash M; Polimeni G; Susin C; Shanaman RH; Rohrer MD; Wozney JM; Hall J
    J Clin Periodontol; 2008 Nov; 35(11):1001-10. PubMed ID: 18976397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior mandible (Type II bone) in dogs.
    Wikesjö UM; Xiropaidis AV; Qahash M; Lim WH; Sorensen RG; Rohrer MD; Wozney JM; Hall J
    J Clin Periodontol; 2008 Nov; 35(11):985-91. PubMed ID: 18976395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-7 (rhBMP-7/rhOP-1): histological observations.
    Susin C; Qahash M; Polimeni G; Lu PH; Prasad HS; Rohrer MD; Hall J; Wikesjö UM
    J Clin Periodontol; 2010 Jun; 37(6):574-81. PubMed ID: 20345394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth of new bone guided by implants in a murine calvarial model.
    Freilich M; M Patel C; Wei M; Shafer D; Schleier P; Hortschansky P; Kompali R; Kuhn L
    Bone; 2008 Oct; 43(4):781-8. PubMed ID: 18589010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone apposition to titanium implants biocoated with recombinant human bone morphogenetic protein-2 (rhBMP-2). A pilot study in dogs.
    Becker J; Kirsch A; Schwarz F; Chatzinikolaidou M; Rothamel D; Lekovic V; Laub M; Jennissen HP
    Clin Oral Investig; 2006 Sep; 10(3):217-24. PubMed ID: 16683108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased osseointegration effect of bone morphogenetic protein 2 on dental implants: an in vivo study.
    Yoo D; Tovar N; Jimbo R; Marin C; Anchieta RB; Machado LS; Montclare J; Guastaldi FP; Janal MN; Coelho PG
    J Biomed Mater Res A; 2014 Jun; 102(6):1921-7. PubMed ID: 23853058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Space-providing expanded polytetrafluoroethylene devices define alveolar augmentation at dental implants induced by recombinant human bone morphogenetic protein 2 in an absorbable collagen sponge carrier.
    Wikesjö UM; Qahash M; Thomson RC; Cook AD; Rohrer MD; Wozney JM; Hardwick WR
    Clin Implant Dent Relat Res; 2003; 5(2):112-23. PubMed ID: 14536046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyapatite and collagen combination-coated dental implants display better bone formation in the peri-implant area than the same combination plus bone morphogenetic protein-2-coated implants, hydroxyapatite only coated implants, and uncoated implants.
    Lee SW; Hahn BD; Kang TY; Lee MJ; Choi JY; Kim MK; Kim SG
    J Oral Maxillofac Surg; 2014 Jan; 72(1):53-60. PubMed ID: 24331565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peri-implant reactivity and osteoinductive potential of immobilized rhBMP-2 on titanium carriers.
    Chatzinikolaidou M; Lichtinger TK; Müller RT; Jennissen HP
    Acta Biomater; 2010 Nov; 6(11):4405-21. PubMed ID: 20558328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone formation at porous titanium implants coated with multiple layers of recombinant human bone morphogenetic protein-2 cDNA plasmid in the posterior mandible in dogs.
    He FM; Shan HQ; Shen JW; Jiang QH
    Int J Oral Maxillofac Implants; 2013; 28(6):1648-54. PubMed ID: 24278934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of combined delivery of recombinant human bone morphogenetic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium-phosphate-coated implants on osseointegration.
    Ramazanoglu M; Lutz R; Ergun C; von Wilmowsky C; Nkenke E; Schlegel KA
    Clin Oral Implants Res; 2011 Dec; 22(12):1433-9. PubMed ID: 21418332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of recombinant human BMP-2 on bone-implant osseointegration: biomechanical testing and histomorphometric analysis.
    Lan J; Wang ZF; Shi B; Xia HB; Cheng XR
    Int J Oral Maxillofac Surg; 2007 Apr; 36(4):345-9. PubMed ID: 17300917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of implants coated with rhBMP-2 using two different coating strategies: a critical-size supraalveolar peri-implant defect study in dogs.
    Lee J; Decker JF; Polimeni G; Cortella CA; Rohrer MD; Wozney JM; Hall J; Susin C; Wikesjö UM
    J Clin Periodontol; 2010 Jun; 37(6):582-90. PubMed ID: 20345393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of implants coated with recombinant human bone morphogenetic protein-2 and vacuum-dried using the critical-size supraalveolar peri-implant defect model in dogs.
    Decker JF; Lee J; Cortella CA; Polimeni G; Rohrer MD; Wozney JM; Hall J; Susin C; Wikesjö UM
    J Periodontol; 2010 Dec; 81(12):1839-49. PubMed ID: 20629551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of rhBMP-2 around endosseous implants with and without membranes in the canine model.
    Jones AA; Buser D; Schenk R; Wozney J; Cochran DL
    J Periodontol; 2006 Jul; 77(7):1184-93. PubMed ID: 16805681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants.
    Cochran DL; Schenk R; Buser D; Wozney JM; Jones AA
    J Periodontol; 1999 Feb; 70(2):139-50. PubMed ID: 10102551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-7 (rhBMP-7/rhOP-1): radiographic observations.
    Leknes KN; Yang J; Qahash M; Polimeni G; Susin C; Wikesjö UM
    J Clin Periodontol; 2008 Oct; 35(10):914-9. PubMed ID: 18727659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.